Literature DB >> 20729945

Strategies for treating cutaneous T-cell lymphoma: part 1: remission.

Jo-Ann Latkowski, Peter Heald.   

Abstract

In this article, the management of cutaneous T-cell lymphoma will be presented in terms of the strategies that guide treatment. With the strategies and goals in mind, treatment options to achieve a measurable goal will be presented. The treatments presented in this article are those utilized to reliably achieve a remission. If remission is not achieved, a patient's management plan must be changed. The landmarks that help guide the therapy plan will be discussed.

Entities:  

Year:  2009        PMID： 20729945      PMCID： PMC2923960     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


  21 in total

1.  Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.

Authors:  Arturo Molina; Jasmine Zain; Daniel A Arber; Maria Angelopolou; Margaret O'Donnell; Joyce Murata-Collins; Stephen J Forman; Auayporn Nademanee
Journal:  J Clin Oncol       Date:  2005-09-01       Impact factor: 44.544

2.  Home UV phototherapy of early mycosis fungoides: long-term follow-up observations in thirty-one patients.

Authors:  K S Resnik; E C Vonderheid
Journal:  J Am Acad Dermatol       Date:  1993-07       Impact factor: 11.527

3.  Ointment-based mechlorethamine treatment for mycosis fungoides.

Authors:  N M Price; R T Hoppe; D G Deneau
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

4.  Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides.

Authors:  A Hofer; L Cerroni; H Kerl; P Wolf
Journal:  Arch Dermatol       Date:  1999-11

5.  Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (Mycosis Fungoides).

Authors:  L D Wilson; B M Kacinski; G W Jones
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

6.  Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients.

Authors:  H S Zackheim; E H Epstein; W R Crain
Journal:  J Am Acad Dermatol       Date:  1990-05       Impact factor: 11.527

7.  Topical mechlorethamine therapy for early stage mycosis fungoides.

Authors:  D L Ramsay; P S Halperin; A Zeleniuch-Jacquotte
Journal:  J Am Acad Dermatol       Date:  1988-10       Impact factor: 11.527

Review 8.  Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation.

Authors:  K E Herbert; A Spencer; A Grigg; G Ryan; C McCormack; H M Prince
Journal:  Bone Marrow Transplant       Date:  2004-09       Impact factor: 5.483

9.  Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up.

Authors:  J J Herrmann; H H Roenigk; A Hurria; T M Kuzel; E Samuelson; A W Rademaker; S T Rosen
Journal:  J Am Acad Dermatol       Date:  1995-08       Impact factor: 11.527

10.  Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.

Authors:  E N Mostow; S L Neckel; L Oberhelman; T F Anderson; K D Cooper
Journal:  Arch Dermatol       Date:  1993-06
View more
  2 in total

1.  Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Cutaneous T Cell Lymphoma.

Authors:  Jennifer A Salant; Niloufer Khan; Judith E Nelson; Moe Norton-Westbrook; Anjali V Desai
Journal:  J Palliat Med       Date:  2021-12-31       Impact factor: 2.947

Review 2.  Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience.

Authors:  Larisa J Geskin; Martine Bagot; Emmilia Hodak; Ellen J Kim
Journal:  Dermatol Ther (Heidelb)       Date:  2021-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.